РЕЗУЛЬТАТЫ ЛЕЧЕНИЯ ОСТРОГО ЛИМФОБЛАСТНОГО ЛЕЙКОЗА У ДЕТЕЙ ПО ПРОТОКОЛУ ALL IC-BFM 2002
2016
Beneficial chemotherapy programs along with improved supportive care methods promoted acute lymphoblastic leukemia (ALL) from fatal to potentially curable disease. Leukemogenesis study and prognostic factor analysis became the basis for identification of prognostic groups and design of riskadapted chemotherapy for ALL. One of the modern treatment protocols for ALL is ALL IC-BFM 2002, its treatment results are presented in the current article. This protocol occurs to be highly-effective and results in high long-term survival rates: 10-year overall survival was 90,4±2,6%, event-free — 82,5±3,4%, and relapse-free — 87,3±3,1%.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
2
Citations
NaN
KQI